Recent research connects propionic acidemia to the pathogenesis of ASD, opening up a new subfield of clinical research that has the potential to immediately help patients find relief from symptoms.
Treatment for aggressive behavior in patients with autism has historically been elusive, but new research suggests that treating sleep problems may be the key to symptom relief.
Emerging research suggests that autism-associated behavioral abnormalities are modulated by gut physiology, and dietary supplements like probiotics and short chain fatty acids may prove to be effective therapeutic options.
Alternative treatments for autism gives clinicians, parents, and patients new opportunities for creating symptom relief, but any treatment strategy must be tailored to the unique needs of each individual.
A recently-developed blood-based peripheral marker that can be used to identify autism-associated ileocolitis could help clinicians develop more effective, patient-specific strategies for symptom management.
Butyrate, also known as butyric acid, is an emerging treatment option for a wide range of health conditions, particularly gastrointestinal disorders and GI-associated neurological conditions like autism spectrum disorder (ASD).
Autism spectrum disorder (ASD) is a multifaceted neurological condition with a multitude of emotional, cognitive, behavioral, and physical symptoms that may vary in presentation amongst individuals.
The relationship between autism and food is inherently complex, but provides important opportunities for both prevention and treatment of this challenging condition.
As parents and clinicians seek to find symptom relief for children with autism spectrum disorder (ASD), complementary therapies are increasingly being used to enhance outcomes.
An increasingly detailed and interconnected body of scientific literature is establishing the connection between the pathology of autism spectrum disorder (ASD) and the gut microbiome.